| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 93,435 | 125,754 | 99,646 | | Cost of Revenue | 41,973 | 53,557 | 45,961 | | | Gross Profit | 51,462 | 72,197 | 53,685 | | | Operating Expenses | | Research Development | 25,840 | 31,004 | 32,555 | | Selling General and Administrative | 46,062 | 38,254 | 35,290 | | Non Recurring | 834 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (21,274) | 2,939 | (14,160) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 173 | 1,842 | 1,562 | | Earnings Before Interest And Taxes | (21,101) | 4,781 | (12,598) | | Interest Expense | 271 | 846 | 915 | | Income Before Tax | (21,372) | 3,935 | (13,513) | | Income Tax Expense | (412) | 559 | 404 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (20,960) | 3,376 | (13,917) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (20,960) | 3,376 | (13,917) | | Preferred Stock And Other Adjustments |
-
| (5,980) |
-
| | | Net Income Applicable To Common Shares | ($20,960) | ($2,604) | ($13,917) |
|
0.07% Nasdaq 
0.27%
Income Statement
